HSBC Holdings’s Zomedica Corp. ZOM Stock Holding History

HSBC Holdings’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-81,222	Closed	-$27K	–	3568
2022 Q1	$27K	Buy	81,222 +123	+0.2%	+$40	﹤0.01%	3229
2021 Q4	$26K	Buy	81,099 +706	+0.9%	+$318	﹤0.01%	3226
2021 Q3	$43K	Sell	80,393 -10,931	-12%	-$6.45K	﹤0.01%	2934
2021 Q2	$76K	Buy	+91,324	New	+$85.1K	﹤0.01%	2870

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

HSBC Holdings's ZOM Position: Q2 2022 in Review

HSBC Holdings sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 81,222 shares — an estimated $27K sold.

HSBC Holdings first reported a position in ZOM in Q2 2021 and held it in 4 quarters. The position peaked at $76K in Q2 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

HSBC Holdings reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
HSBC Holdings sold 81,222 Zomedica Corp. shares in Q2 2022, an estimated $27K.
HSBC Holdings first reported a position in Zomedica Corp. in Q2 2021 and held it in 4 quarters.
HSBC Holdings's Zomedica Corp. position peaked at $76K in Q2 2021.
97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on HSBC Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.